Economics of non-communicable diseases in India
Non-communicable diseases have been established as a clear threat not only to human health, but also to development and economic growth. The evidence is compelling. India stands to incur a loose $4.58 trillion between 2012 and 2030 due to Non-Communicable Diseases (NCDs) and mental health conditions. However, these losses are not inevitable; options exist for actions that policy-makers and businesses can take today to significantly reduce these costs. Developed by the World Economic Forum and the Harvard School of Public Health, the “Economics of Non-Communicable Diseases in India” provides new data on the costs of NCDs in India, the views of business leaders on the impact of NCDs and estimations of the ROI of specific India-based interventions.
Related Content
- Global mapping report on multisectoral actions to strengthen the prevention and control of noncommunicable diseases and mental health conditions: experiences from around the world
- Accelerating global health: pathways to health equity for the G20
- Investing in health and the economy: curbing the crisis of non-communicable diseases
- WHO report on cancer- setting priorities, investing wisely & providing care for all
- Economic effects of the double burden of malnutrition
- Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants